Cencora's Revenue by Segment
In fiscal year 2025, Cencora's revenue by segment (products & services) are as follows:
- Animal Health: $5.69 B
- International Healthcare Solutions: $30.37 B
- Pharmaceutical Distribution: $285.29 B
Learn more about Cencora’s Revenue by Geography
Check out competitors to Cencora in a side-by-side comparison.
Explore additional financial metrics for Cencora.
Cencora's Revenue Share by Segment
| Animal Health | 5042549000 |
|---|---|
| International Healthcare Solutions | 27418679000 |
| Pharmaceutical Distribution | 229716669000 |
| Animal Health | 5365518000 |
|---|---|
| International Healthcare Solutions | 28627542000 |
| Pharmaceutical Distribution | 259973909000 |
| Animal Health | 5694517000 |
|---|---|
| International Healthcare Solutions | 30366323000 |
| Pharmaceutical Distribution | 285287506000 |
The above chart shows Cencora's revenue percentage share by segment (products and services).
In fiscal year 2023, Cencora's revenue by segment is as follows:
- Animal Health generated $5.04 B in revenue, representing 1.92% of its total revenue.
- International Healthcare Solutions generated $27.42 B in revenue, representing 10.46% of its total revenue.
- Pharmaceutical Distribution generated $229.72 B in revenue, representing 87.62% of its total revenue.
The biggest segment for Cencora is the Pharmaceutical Distribution, which represents 87.62% of its total revenue.
The smallest segment for Cencora is the Animal Health, which represents 1.92% of its total revenue.
The above chart shows Cencora's revenue percentage share by segment (products and services).
In fiscal year 2024, Cencora's revenue by segment is as follows:
- Animal Health generated $5.37 B in revenue, representing 1.83% of its total revenue.
- International Healthcare Solutions generated $28.63 B in revenue, representing 9.74% of its total revenue.
- Pharmaceutical Distribution generated $259.97 B in revenue, representing 88.44% of its total revenue.
The biggest segment for Cencora is the Pharmaceutical Distribution, which represents 88.44% of its total revenue.
The smallest segment for Cencora is the Animal Health, which represents 1.83% of its total revenue.
The above chart shows Cencora's revenue percentage share by segment (products and services).
In fiscal year 2025, Cencora's revenue by segment is as follows:
- Animal Health generated $5.69 B in revenue, representing 1.77% of its total revenue.
- International Healthcare Solutions generated $30.37 B in revenue, representing 9.45% of its total revenue.
- Pharmaceutical Distribution generated $285.29 B in revenue, representing 88.78% of its total revenue.
The biggest segment for Cencora is the Pharmaceutical Distribution, which represents 88.78% of its total revenue.
The smallest segment for Cencora is the Animal Health, which represents 1.77% of its total revenue.
Summary Table
| Products & Services (Percent Share) | 2023 | 2024 | 2025 |
|---|---|---|---|
| International Healthcare Solutions | 10.46% | 9.74% | 9.45% |
| Animal Health | 1.92% | 1.83% | 1.77% |
| Pharmaceutical Distribution | 87.62% | 88.44% | 88.78% |
| Total Revenue | 100% | 100% | 100% |
Cencora's Segments Revenue Trend
The above chart shows the revenue trend of different segments of Cencora.
In fiscal year 2025, the Pharmaceutical Distribution generated the most revenue ($285.29 B), and the Animal Health generated the least revenue ($5.69 B).
Cencora's Revenue Growth Drivers
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Summary Table
| Products & Services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Animal Health | $5.04 B - |
$5.37 B
6.40%
|
$5.69 B
6.13%
|
| International Healthcare Solutions | $27.42 B - |
$28.63 B
4.41%
|
$30.37 B
6.07%
|
| Pharmaceutical Distribution | $229.72 B - |
$259.97 B
13.17%
|
$285.29 B
9.74%
|
| Total Revenue | $262.18 B - |
$293.97 B
12.13%
|
$321.35 B
9.31%
|
Related
-
Agilent Technologies Revenue by Segment
-
Eli Lilly and Company Revenue by Segment
-
Stryker Corporation Revenue by Segment
-
Johnson & Johnson Revenue by Segment
-
AbbVie Revenue by Segment
-
Merck & Co. Revenue by Segment
-
Thermo Fisher Scientific Revenue by Segment
-
Abbott Laboratories Revenue by Segment
-
Danaher Corporation Revenue by Segment
-
Amgen Revenue by Segment
